日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.

组蛋白去乙酰化酶抑制剂恩替诺特联合 13-顺式维甲酸治疗实体瘤患者的 I 期研究

Pili R, Salumbides B, Zhao M, Altiok S, Qian D, Zwiebel J, Carducci M A, Rudek M A

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor

过氧化物酶体增殖物激活受体γ和类视黄醇X受体的配体诱导人脂肪肉瘤细胞的终末分化

Tontonoz, P; Singer, S; Forman, B M; Sarraf, P; Fletcher, J A; Fletcher, C D; Brun, R P; Mueller, E; Altiok, S; Oppenheim, H; Evans, R M; Spiegelman, B M

Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity

肌肉中赫格林刺激的乙酰胆碱受体基因表达:MAP激酶的必要性以及独立于电活动的平行抑制通路的证据

Altiok, N; Altiok, S; Changeux, J P

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A

PPARγ诱导细胞周期停滞:通过下调PP2A抑制E2F/DP DNA结合活性

Altiok, S; Xu, M; Spiegelman, B M